Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 1
1990 2
1995 1
1996 1
1997 2
2008 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901.
Barrett SD, Bridges AJ, Dudley DT, Saltiel AR, Fergus JH, Flamme CM, Delaney AM, Kaufman M, LePage S, Leopold WR, Przybranowski SA, Sebolt-Leopold J, Van Becelaere K, Doherty AM, Kennedy RM, Marston D, Howard WA Jr, Smith Y, Warmus JS, Tecle H. Barrett SD, et al. Among authors: fergus jh. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6501-4. doi: 10.1016/j.bmcl.2008.10.054. Epub 2008 Oct 15. Bioorg Med Chem Lett. 2008. PMID: 18952427
PD 115,199: an antagonist ligand for adenosine A2 receptors.
Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hays SJ. Bruns RF, et al. Among authors: fergus jh. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):64-9. doi: 10.1007/BF00165038. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 3574493
Design of peptidomimetic ligands for the pp60src SH2 domain.
Plummer MS, Lunney EA, Para KS, Shahripour A, Stankovic CJ, Humblet C, Fergus JH, Marks JS, Herrera R, Hubbell S, Saltiel A, Sawyer TK. Plummer MS, et al. Among authors: fergus jh. Bioorg Med Chem. 1997 Jan;5(1):41-7. doi: 10.1016/s0968-0896(96)00200-3. Bioorg Med Chem. 1997. PMID: 9043656 No abstract available.